Cipla hopes to generate sustainable top-line growth in FY18 Ruby Khatun Khatun13 Aug 2017 9:20 AM ISTMumbai: Cipla on Friday said even as the industry faces several hurdles, the government's new drug policy will boost the pharma sector and the company...
Mylan cuts forecasts on delays in new drugs, weak prices Ruby Khatun Khatun13 Aug 2017 9:10 AM ISTMylan NV said on Wednesday that delays in launching key new drugs and eroding prices for generics in the United States will hurt its profitability...
Lupin appoints Manju Deshbandhu Gupta as Chairman Ruby Khatun Khatun12 Aug 2017 12:23 PM ISTNew Delhi: Drug major Lupin appointed Manju Deshbandhu Gupta as Chairman of the company with immediate effect.The company's board unanimously...
Zydus Pharma recalls 3.31 lakh bottles of seizure drug in US Ruby Khatun Khatun12 Aug 2017 12:20 PM ISTNew Delhi: Zydus Pharmaceuticals USA Inc is recalling from the US market over 3.31 lakh bottles of Divalproex Sodium delayed release tablets used for...
Sun Pharma buys stake in US based biopharma company Ruby Khatun Khatun12 Aug 2017 9:40 AM ISTMumbai: Drug maker, Sun Pharma has acquired 15.9% stake in US-based biopharmaceutical company, Krystal Biotech Inc.One of the wholly-owned...
Billionaire father and son duo turned Cadila Healthcare into world beater Ruby Khatun Khatun11 Aug 2017 10:00 AM ISTBy Ari AltstedterIf the stock market is any guide, Sharvil Patel has just inherited one of the top generic drug manufacturers in the world. Now, he...
Sun Pharma drops over 5 percent; shares hit 52-week low Ruby Khatun Khatun11 Aug 2017 9:25 AM ISTNew Delhi: Shares of Sun Pharmaceutical Industries fell by over 5 per cent amid reports that its subsidiary Taro Pharmaceutical Industries reported...
Zydus Cadila gets USFDA nod to market hypertension drug Ruby Khatun Khatun11 Aug 2017 9:16 AM ISTNew Delhi: Drug firm Zydus Cadila has received the US health regulator's nod to market Diltiazem Hydrochloride capsules, used to treat high blood...
Lupin receives USFDA nod for cholesterol drug Ruby Khatun Khatun11 Aug 2017 9:15 AM ISTNew Delhi: Drug firm Lupin has received approval from the US health regulator to market Pitavastatin tablets used for lowering cholesterol.In a BSE...
Roche unloads some rights to drug hopeful after asthma trial disappointment Ruby Khatun Khatun11 Aug 2017 9:14 AM ISTZURICH: Roche is offloading some rights to what was once one of its top drug prospects, lebrikizumab, for payments which could total more than $1...
Bristol-Myers Squibb to buy IFM Therapeutics to strengthen cancer pipeline Ruby Khatun Khatun11 Aug 2017 9:14 AM ISTBristol-Myers Squibb Co said it would buy privately held IFM Therapeutics for an upfront payment of $300 million, as the drugmaker looks to bolster...
Pharma, medical devices should be under one ministry: Mansukh L Mandaviya Ruby Khatun Khatun10 Aug 2017 10:00 AM ISTNew Delhi: The Department of Pharmaceuticals (DoP) feels that subjects and regulatory bodies related to pharmaceuticals and medical devices should...
